RE:RE:HPQ- MD&A- Tie in with PYRA great and informative post from topseeker regarding HPQ Silicon and the connection/tie in with PyroGenesis. Thanks to topseeker for this.
Folks, remember that PyroGenesis owns a substantial amount of shares and warrants in HPQ Silicon. From Pyrogenesis' Q3 results:
Shares in HPQ Silicon: 25,074,200
Warrants in HPQ: 27,344,600
Great to see that PyroGenesis has such a vested interest in HPQ Silicon/PUREVAP. For PyroGenesis to invest so much of their own funds into HPQ Silicon, this speaks volumes to the value of PUREVAP and where the PUREVAP QRR and the PUREVAP NSiR are headed. Exciting times!
Long and Strong in PyroGenesis and HPQ Silicon!
topseeker wrote: Good Evening All,
Thanks again to Hilbertk, Developbc, and others for putting the facts out there to Readers again to remind us what PYR is about.
The following are some excerpts from the MD&A that was released by HPQ today with a mention of PYR. Enjoy the read :
OVERALL PERFORMANCE DURING 2019
On November 25, 2019, the Company announced that it is actively evaluating a joint venture with PyroGenesis to manufacture nanoscale (Si) silicon powders for next-generation Li-ion Si batteries.
On September 4, 2019, HPQ announced that a new provisional patent application covering a critical part of the PUREVAP™ Quartz Reduction Reactor (QRR) process has been filed.
On July 11, 2019, HPQ announced that PyroGenesis calculated that the maximum scaled up size of a single PUREVAP™QRR reactor would allow the production of 2,500 metric tonnes (“MT”) of Silicon Metal per year. The total capacity of any PUREVAP™ QRR plant is therefore scalable by increments of 2,500 MT per year.
On June 17, 2019, HPQ announced that the PUREVAP ™ QRR process could significantly reduce the cost of raw materials for silicon manufacturing, thereby reducing the number of operations compared to the sector.
On April 25, 2019, HPQ announced an evolution through tests on the commercial feasibility validation on GEN2 PUREVAP ™ and identified a new operational parameter.
On February 26, 2019, HPQ annouced that GEN2 PUREVAP™ Commercial Scalability Proof of Concept tests demonstrated that semi-continuous operation improves the PUREVAP™ QRR Production Yield.
Working with PyroGenesis Canada Inc, (“PyroGenesis”) a high-tech company that designs, develops, manufactures and commercializes plasma - based processes, HPQ is developing:
The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential; HPQ is in the process of becoming the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon (3N – 4N Si); HPQ is the owner of the PUREVAP™ QRR Intellectual Property
The PUREVAPTM Silicon Nano Reactor (SiNR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires; HPQ objective is to become the lowest cost manufacturer of spherical Si nanopowders annd silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
On January 15, 2020, HPQ announced that the PUREVAPTM GEN 2 reactor has been modified and has successfully produced spherical nano-powders from silicon metal with a primary size <500 nanometers (<0.5 ).
On April 15, 2020, HPQ announced promising results emanating from electrochemical performance tests performed on materials produced with our GEN2 PUREVAPTM Quartz Reduction Reactor (“QRR”). Tests conducted at the Institut National de Recherche Scientifique (INRS), on material produced with the GEN2 PUREVAPTM QRR (“GEN2”), demonstrated its potential to advantageously replace graphite in Lithium-ion (Li-ion) batteries while limiting the disadvantages inherent to silicon anodes. The tests on material produced with the GEN2 are part of a series of initiatives being undertaken by HPQ in order to become a producer of silicon (Si) materials suitable for the next generation Li-Ion batteries. The tests were completed at the Centre nergie Matriaux Tlcommunications (EMT) of the INRS by Professor Lionel ROU under an NSERC Engage Grant and a NSERC Engage plus Grant. The exact composition of the material produced with the GEN2 as well as how the electrodes used in the tests were prepared are trade secrets of HPQ. HPQ will take the necessary steps to protect this invention. As part of this research project, HPQ retains all intellectual property rights in relation to this invention.
On September 28, 2015, the Corporation concluded a Development and Exclusivity Agreement with PyroGenesis. In return for the Exclusive Right to use the PyroGenesis-developed technology, it must make the following payments:
2020, the highest between 10% of Si sales or $150,000;
2021, the highest between 10% of Si sales or $200,000;
2022 and after, the highest between 10% of Si sales or $250,000.
As at December 31, 2019, the remaining total commitment for the purchase of the Pilot Plant Equipment was approximately $2,540,000 of which an amount of $1,950,000 is a deposit on a contract. The Corporation has obtained the approval of the TSX-Venture Exchange for the line of credit on equity in an amount of $1,500,000 agreed to by PyroGenesis. This line of credit is only to be used if there are any cost overruns that could be incurred for the pilot plant equipment after the end of the test period in 2019 and until December 31, 2020.
Best wishes All, good health,
Good Fortune,
Sincerely,
Topseeker
.